tirzepatide fda approved weight loss Eli Lilly's Weight-Loss Drug Gets Approval Breaking News: FDA Approves Tirzepatide

Results of the phase 3b TOGETHER-PsA trial showed ixekizumab administered together with tirzepatide in comorbid overweight or obese adults with psoriatic arthritis showed clinically meaningful improvement of psoriatic disease, physical function, weight reduction, & quality-of-life, with no new safety concerns Read the full results in Arthritis & Rheumatology Ixekizumab with Tirzepatide Improves Psoriatic Arthritis in Overweight Adults Results of the phase 3b TOGETHER-PsA trial showed ixekizumab administered together with tirzepatide in comorbid overweight or obese adults with psoriatic arthritis showed clinically meaningful improvement of psoriatic disease, physical function, weight reduction, & quality-of-life, with no new safety concerns Read the full results in Arthritis & Rheumatology To view or add a comment, sign in More Relevant Posts Super interesting results of Together PsA and the idea of combining anti-cytokine approaches with a modulator of the GLP1 axis

This is where Pillo can quietly help

Ethical Approval This study was conducted in accordance with the Declaration of Helsinki

After 16 weeks, the test groups HQ-CT scores were on average five points better than the placebo group and 13 points better than their baseline scores from three years prior

However, this can be associated with a drop in blood calcium levels, and thus, close monitoring is required